TESARO Announces Collaboration to Evaluate ZEJULA® in Combination With Anti-PD-L1 Cancer Immunotherapy and MEK Inhibitor in Platinum-Sensitive Ovarian Cancer
June 05, 2018 08:30 ET
|
TESARO, Inc.
WALTHAM, Mass., June 05, 2018 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that it has entered into a clinical collaboration with...
California Life Sciences Association (CLSA) Adds Leaders from Genentech, Sanford Burnham Prebys Medical Discovery Institute and OncoCyte to Board of Directors
November 23, 2015 08:06 ET
|
California Life Sciences Association
SOUTH SAN FRANCISCO and SAN DIEGO, Nov. 23, 2015 (GLOBE NEWSWIRE) -- California Life Sciences Association (CLSA), today announced that its board of directors appointed three new members: William...
Former Roche Pharmaceuticals CEO Joins Mesoblast Board of Directors
March 05, 2014 19:24 ET
|
Mesoblast
NEW YORK and MELBOURNE, Australia, March 5, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB; USOTC:MBLTY) today announced that William M. Burns, former Chief...
Dr. Napoleone Ferrara Joins the New Scientific Advisory Board of Protelica Incorporated
September 10, 2013 06:30 ET
|
Protelica, Inc.
HAYWARD, Calif., Sept. 10, 2013 (GLOBE NEWSWIRE) -- Dr. Napoleone Ferrara, a world renowned authority on angiogenesis, and the developer of the anti-cancer drug Avastin has joined Protelica's newly...
Singularity University Announces New Corporate Partnership With Genentech to Explore the Future of Exponentially Advancing Technologies
February 06, 2012 13:10 ET
|
Singularity University
MOUNTAIN VIEW, Calif., Feb. 6, 2012 (GLOBE NEWSWIRE) -- Singularity University (SU), the only educational institution uniquely focused on the impact and opportunities presented by exponentially...